These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 5375884)

  • 21. Proteinuria, hyperlipidemia, and the kidney.
    Hutchison FN
    Miner Electrolyte Metab; 1993; 19(3):127-36. PubMed ID: 8232099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Triglyceride tolerance test: is it useful.
    Dayal AK; Seshadri MS; Gijsbers A; Cherian AM; Thomas K
    J Assoc Physicians India; 1988 Feb; 36(2):185-6. PubMed ID: 3182660
    [No Abstract]   [Full Text] [Related]  

  • 23. [Lipoprotein disorders in chronic kidney failure, nephrotic syndrome and dialysis].
    Kes P; Reiner Z; Brunetta B
    Lijec Vjesn; 2002; 124(11-12):372-7. PubMed ID: 12679979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperlipoproteinemia of aminonucleoside-induced nephrotic syndrome--modulation by glucocorticoids and triiodothyronine.
    Shafrir E
    Isr J Med Sci; 1996 Jun; 32(6):390-7. PubMed ID: 8682644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A hyperlipemia syndrome in infancy with rapidly fatal evolution.
    Jaeken J; Casteels-van Daele M; Harvengt L; Corbeel L; Broeckaert-Van Orshoven ; Van Damme B; Kenis H; Eeckels R
    Helv Paediatr Acta; 1973 Mar; 28(1):67-71. PubMed ID: 4696147
    [No Abstract]   [Full Text] [Related]  

  • 26. Estimation of the phospholipid phosphorus turnover time in man: studies in normal individuals, in patients with the nephrotic syndrome and in other types of hyperlipemia.
    MOSER HW; EMERSON K
    J Clin Invest; 1955 Aug; 34(8):1286-96. PubMed ID: 13242661
    [No Abstract]   [Full Text] [Related]  

  • 27. [Characteristics of lipoprotein metabolism impairments in nephrotic syndrome].
    Titov VN; Tvorogova MG; Levitova EN; Krylova EA
    Vopr Med Khim; 1983; 29(2):17-23. PubMed ID: 6858031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term effect of lovastatin on lipoprotein profile in patients with primary nephrotic syndrome.
    Prata MM; Nogueira AC; Pinto JR; Correia AM; Vicente O; Rodrigues MC; Miguel MJ
    Clin Nephrol; 1994 May; 41(5):277-83. PubMed ID: 8050207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Questions about a case of congenital nephrotic syndrome].
    Watine J
    Ann Biol Clin (Paris); 1999; 57(1):110. PubMed ID: 9920977
    [No Abstract]   [Full Text] [Related]  

  • 30. Serum remnant lipoprotein levels in nephrotic syndrome.
    Kinoshita H; Uezono S; Fukudome K; Yokota N; Hisanaga S; Fujimoto S; Eto T
    Clin Nephrol; 2001 Mar; 55(3):263-4. PubMed ID: 11316252
    [No Abstract]   [Full Text] [Related]  

  • 31. Serum cholesterol and triglycerides in childhood nephrotic syndrome in northern Nigeria. A preliminary report.
    Abdurrahman MB; Suvarnabai PC; Aikhionbare HA; Timoszyk J
    Trop Geogr Med; 1984 Mar; 36(1):7-11. PubMed ID: 6729984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The potential role of HMG-CoA reductase inhibitors in pediatric nephrotic syndrome.
    Prescott WA; Streetman DA; Streetman DS
    Ann Pharmacother; 2004 Dec; 38(12):2105-14. PubMed ID: 15507504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimental reconstruction of metabolic pattern of lipid nephrosis: key role of hepatic protein synthesis in hyperlipemia.
    MARSH JB; DRABKIN DL
    Metabolism; 1960 Oct; 9():946-55. PubMed ID: 13767173
    [No Abstract]   [Full Text] [Related]  

  • 34. [Study of mixed hyperlipemia with a distinct excess of beta and pre-beta lipoproteins (78 cases)].
    Loeper J; Rouffy J; Loeper J
    Presse Med (1893); 1971 Apr; 79(18):797-800. PubMed ID: 5574509
    [No Abstract]   [Full Text] [Related]  

  • 35. [Nephrotic syndrome: etiology, pathogenesis, clinical course].
    Tareeva IE; Poliantseva LR; Kutyrina IM
    Klin Med (Mosk); 1993 Jan; 71(1):47-51. PubMed ID: 8046908
    [No Abstract]   [Full Text] [Related]  

  • 36. The effects of gemfibrozil on hyperlipidemia in children with persistent nephrotic syndrome.
    Büyükçelik M; Anarat A; Bayazit AK; Noyan A; Ozel A; Anarat R; Aydingülü H; Dikmen N
    Turk J Pediatr; 2002; 44(1):40-4. PubMed ID: 11858378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular disease and the nephrotic syndrome: the other side of the coin.
    Wass V; Cameron JS
    Nephron; 1981; 27(2):58-61. PubMed ID: 7266703
    [No Abstract]   [Full Text] [Related]  

  • 38. [Biochemistry and histology of the nephrotic syndrome in children].
    Rosenkranz A; Thaler H
    Wien Med Wochenschr; 1968 Dec; 118(50):1079-81. PubMed ID: 5728974
    [No Abstract]   [Full Text] [Related]  

  • 39. Pathogenesis of lipid abnormalities in patients with nephrotic syndrome/proteinuria: clinical implications.
    Warwick GL; Packard CJ
    Miner Electrolyte Metab; 1993; 19(3):115-26. PubMed ID: 8232098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uremic lipemia: an unrecognized abnormality in triglyceride synthesis and removal.
    Bagdade JD; Porte D; Curtis FK; Bierman EL
    Trans Assoc Am Physicians; 1968; 81():190-202. PubMed ID: 5721400
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.